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Abstract
No previous analysis has investigated the determinants of screening uptake for breast and cervical cancer screening
for possible spillover effects from one type of screening examination to the other type of screening examination with a
dynamic bivariate panel probit model. For our analysis, we used a dynamic random effects bivariate panel probit model
with initial conditions (Wooldridge-type estimator) and dependent variables were the participation of breast and cervical
cancer screening in the recent year. The balanced panel sample consisted of 844 women from the British Household
Panel Survey (BHPS) from the time period 1992 to 2008. Our analysis showed the high relevance of past screening
behaviour and the importance of state dependency for the same and the other type of cancer screening examinations
even after controlling for covariates and unobserved heterogeneity. The uptake for breast and cervical cancer
screening was higher when the same screening examination was done one or three years earlier. This result is in
accordance with the medical screening programmes in Great Britain. With regard to breast and cervical cancer screening
positive spillover effects existed between screening examinations in the third order lags. Women with a previous visit to a
general practitioner and individuals in the recommended age groups had a higher uptake for breast and cervical cancer
screening. Other socioeconomic and health related variables had non-uniform results in both screening examinations.
Promoting the uptake of one female prevention activity could also enhance the uptake of the other prevention activity.
Keywords: Dynamic panel probit model, Bivariate probit, Preventive medicine, State dependence, Screening, Health
check-ups
JEL classification: C33; C51; I19
Background
Individuals can attend different health check-ups in the
National Health Service (NHS). These include breast can-
cer screening, cervical cancer screening, blood pressure
check, cholesterol test, dental screening and eyesight test.
The NHS Breast Screening Programme has established
policy rules on the invitation to a mammography and the
NHS Cervical Screening Programme has established pol-
icy rules for the invitation to a Pap smear test. High par-
ticipation rates are an important aim for both screening
examinations, because mammographies and cervical
smear tests give the possibility of early detection of breast
cancer and prevention of cervical cancer. Breast and cer-
vical cancers have a high chance to be cured if detected at
an early stage [1, 2].
Previous research with the BHPS has analysed the up-
take for breast and cervical cancer screening in several
studies [3, 4], however the uptake was typically only ana-
lysed for one type of screening examination: Labeit et al.
(2013) analysed the uptake of cervical cancer screening
until 2008 [5] and Carney et al. (2013) analysed the uptake
of breast cancer screening until 2008 [6] and Sabates et al.
(2008) estimated breast and cervical cancer screening not
as separate equations and potential correlated processes
[3]. None of these empirical analyses investigated the up-
take of breast and cervical cancer screening examinations
simultaneously and if there are possible spillover effects
from one type of examination to the other type of examin-
ation with a dynamic bivariate panel probit model.
First, the regulations for the breast and cervical cancer
screening are described: the policy rules for the invitation
with the age of invitation, time periods between different
screening examinations and the different invitation rules
for England, Scotland and Wales and the location in which
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the screening examination is typically done. Second, eco-
nomic models and the relevance for prevention activities
and potential weaknesses are discussed and extensions of
these models with non-economic factors are introduced.
Also, empirical evidence for own analysed variables is dis-
cussed and third, the used dataset is described.
For breast and cervical cancer screening examinations,
explicit policy rules exist detailing the frequency of screen-
ing examinations depending on age limits, cancer history
of first-degree relatives and screening examinations in pre-
vious years. The NHS Breast Screening Programme and
the NHS Cervical Screening Programme are both public
health programmes in Great Britain and they are popula-
tion based screening programmes1. The access to both
screening programmes is not possible outside the relevant
age groups and time intervals. Both programmes issue in-
vitations on regular schedules that cannot be altered and
the women will then make the appointment themselves.
Outside of these programmes mammography or smear
test could take place in order to investigate a symptom or
in a local surveillance arrangements.
The NHS Breast Screening Programme (NHSBSP) is a
national prevention programme in Great Britain which
offers women a mammography [7]. This programme is an
early detection programme for an invasive disease and in
some cases it detects breast cancer in situ. The incidence
of breast cancer rises around age 50 and about 80 % of
new cases were diagnosed in women aged 50 and over, and
14% of all new cases were detected in the age group
between 60 and 64 [8]. Relevant risk factors are reproduct-
ive and hormonal factors, obesity, alcohol and physical
activity [9]. A proportion of about one quarter of breast
cancer cases can be linked to largely modifiable such as
lifestyle and environmental factors [10].
Originally, only women between age 50 and 64 were
invited for the first screening and every three years there-
after, but since 2003 women between age 65 and 70 years
have been invited. More frequent examinations are now
recommended for high risk women (e.g. a first-degree
relative (mother or sister) with breast cancer at a young
age). Mammographies are typically conducted in acute
hospital trusts or in mobile van units.
The NHS Cervical Screening Programme (NHSCSP) is a
national prevention programme in Great Britain which of-
fers women a smear test at different time intervals depend-
ing on age [11]. The aim of this programme is to prevent
cancer by detecting and treating abnormalities in an early
stage which, if left could develop into cancer. One of the
most important risks factors for cervical cancer is infection
with the human papilloma virus (HPV). HPV is an infec-
tion that is spread through sexual contact, and as a conse-
quence, about half of all women will be infected during
their whole lifetime [12]. Some of the women with an HPV
infection will develop cervical cancer. Younger women are
more susceptible to develop cervical cancer and younger
females who have sexual intercourse at an early age and
with a higher number of sexual partners will have a higher
chance to develop cervical cancer in comparison to older
women with few sexual partners [13]. In 2008, as part of
the NHS childhood vaccination programme, the HPV vac-
cination was introduced routinely to all girls aged 12 to 13
in England. Other risk factors for developing cervical can-
cer are an increased duration of oral contraceptive use and
a young age at first full term pregnancy [14]. The registra-
tion of newly diagnosed cases of cervical cancer start to
rise in the age group 20 to 24 and it is highest for women
between 25 and 49 and has one peak for women aged 25
to 29 and another peak for women aged 45 to 49. There-
fore, incidence and mortality rates have different age distri-
butions for both female cancer types with the consequence
of different ages for the first and last invitation by these
programmes.
The age for the first invitation and last invitation to cer-
vical cancer screening varies by region in Great Britain: age
25 in England since 2003, or 20 in Scotland and Wales,
and 20 in England before 2003 [15, 16]. Between the age of
the first invitation and 49, there is a 3 yearly recall period
in all parts of Great Britain since 2003, although before
2003 there was a 3 to 5 yearly recall period policy depend-
ing on the Primary Care Trust, with the majority of Pri-
mary Care Trusts following a 3-year policy [17]. The policy
of a uniform 3 year recall period for women between ages
25–49 was implemented in England in 2003 after a recom-
mendation by the Advisory Committee on Cervical
Screening following an audit funded by Cancer Research
UK and at the same time women between 20 and 24 were
withdrawn from the programme in England. It was con-
cluded that a 3-year recall policy appeared most effective
after an analysis of UK data [18]. No information was avail-
able for us on how quickly each Primary Care Trust in
England implemented the changes to the recall policy. Cer-
vical cancer screening is offered to women aged 50 and
over every three years until age 60; every three years until
age 64 in Wales; and every five years in England until age
64 [15]. Before 2003, a majority of women were screened
every three years [17]. Women who reach the age of 60 in
Scotland, and age 65 in England and Wales are ex-
cluded from the recall system and no longer invited for
cervical cancer screening unless they have had a recent
abnormal result in one of the previous three tests. Cervical
cancer screening examinations can be done by a General
practitioner (GP) or appropriate service provider such as a
woman or family clinic or the genito-urinary medicine
(GUM) department of a hospital [11]. These examinations
are offered as an ‘additional service’ by a GP and most cer-
vical screening examinations are undertaken by a female
practice nurse. Liquid based cytology (LBC) which is an im-
proved way of preparing cervical samples for examination
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in the laboratory was introduced between 2003 and 2008
[19] and the conversion to LBC was completed in October
2008 [11]. For breast and cervical cancer screening, peri-
odic invitations are sent out routinely to women by the pro-
grammes which are based on the NHS registers of GP
patients.
The rules of these programmes are relevant for analysing
the uptake of both screening examinations, because ac-
cording to these policy rules women are invited at certain
time intervals for the screening examinations. There is an
increased likelihood of participating in a screening examin-
ation after the recommended time interval. Also, for both
screening examinations, an inconclusive test in the actual
year may make it necessary for a follow-up control screen-
ing examination in the next year. Control screening exami-
nations as a follow-up are typically done for breast and
cervical cancer screening to check unclear test results.
Economic models and existing empirical evidence
Economic models for the demand of health care in general
and for preventative services in particular are based on
human capital models [20]. This theoretic framework has
been used for modelling the demand of primary and sec-
ondary prevention [21]. Therefore, it is also used in the
case of female cancer screenings such as mammography
and smear testing [22]. Cancer screening examinations
have a self-protection function and improve early detec-
tion of these cancer types and health outcomes [23]. The
problem with economic models for the demand of health
care, including prevention care, is that two important
aspects are typically not considered at the same time in
detail: the distinction between acute and preventative care,
and uncertainty. Some dynamic economic models for the
demand of health care take only uncertainty into consider-
ation. However, there is no distinction made between
acute and preventative care [24]. Acute care describes the
consumption aspect of health, whereas preventative care
describes the investment aspect. The Grossman model
makes the distinction between acute and preventative
care, but uncertainty is not considered in this model [25].
There is only one economic model which explicitly takes
the demand for preventative health care and uncertainty
in a stochastic dynamic framework into consideration
[26]. It is also necessary to analyse non-economic factors
for the uptake of screening examinations and many stud-
ies neglect non-economic factors [27]. The conceptual
framework of our analysis is based on a human capital
approach and inclusion of further non-economic factors.
Hypotheses can be generated for the effect on the de-
mand for preventative services concerning age, education
and household income. It is known that age can have dif-
ferent effects on the demand for breast and cervical can-
cer screening [22, 28]. With respect to breast and cervical
cancer screening, policy rules for issuing the invitation do
exist that state explicitly the time interval for the screen-
ing examinations. For the recommended age intervals, up-
take should be higher than for non-recommended age
intervals. On one hand, according to the Grossman model,
health depreciates as the age increases, and the need to
maintain health increases. As a consequence, the demand
for prevention activities, such as breast and cervical cancer
screening would increase with age. On the other hand,
older women have a shorter life span and pay-off period
for their investment in breast and cervical cancer screen-
ing. Therefore, the effect of increasing age on the uptake
for both screening examinations cannot be predicted with
confidence. Empirical studies often find a negative rela-
tionship between age and uptake for breast and cervical
cancer screening [22, 29]. A higher educational level may
be expected to lead to an increase in the uptake for breast
and cervical cancer screening, because women with a
higher education level have a higher efficiency of health
production, self-efficacy, motivation, awareness and know-
ledge about the importance of prevention [21, 30]. How-
ever, there is also contradicting empirical evidence; for
example, it had been found in one empirical study from
Denmark that a high level of education increased the rela-
tive risk for never taking part in a mammography in com-
parison to always taking part [31]. A higher household
income leads to an increase of time in perfect health and
therefore the demand for both screening examinations
should increase [20]. The effect of increasing household
income on breast and cervical cancer screening uptake
was confirmed in several studies [22, 28, 32]. It can be ex-
pected that the effect of increasing household income
should be either weaker or not existent in Great Britain
when compared to other countries, because both cancer
screening examinations are free of charge in Great Britain.
The chance that a woman will visit a breast and cervical
cancer screening examination is dependent on further non-
economic factors such as previous screening history and
individual and household characteristics. We generate
hypotheses and discuss existing empirical evidence. The
history of breast or cervical cancer screening examinations
has a predictive value for uptake in the recent period, i.e.
the past screening behaviour is correlated with the current
behaviour [6, 27, 30]. Cohabitation status can be an indica-
tor of social support, women living in a partnership being
able to exchange information with their partners about
health check-ups in general and cancer screenings in par-
ticular. This hypothesis was confirmed by two empirical
studies which analysed breast and cervical screening exami-
nations. It has been found that women who lived in co-
habitation in Sweden had a higher uptake for both
screening examinations [33, 34]. In Great Britain, two stud-
ies included the number of children as a control variable
and found that women with a higher number of children
attended breast and cancer screening examinations less
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often [30, 35]. Employment was added as a further control
variable, because women who work may have higher op-
portunity costs in comparison to unemployed and retired
women. In a systematic review that analysed the influence
of different determinants on the uptake of different health
check-ups, it was found that the influence of employment
for the uptake of breast and cervical cancer screening was
mixed [27]. The GP plays a role as gatekeeper in the health
care system and can give advice and information about the
importance of breast and cervical cancer screening exami-
nations. Thus, the uptake of both health check-ups should
be enhanced by previous GP visits [36, 37]. Registration
with a GP is a necessary condition for receiving an invita-
tion letter for breast and cervical cancer screening and rou-
tine periodic invitations are sent from the National Health
Service (NHS) registers of GP patients according to the rec-
ommended interval for breast and cervical cancer screen-
ing. Change of residence to a new address of a woman
lowers the chance of receiving an invitation letter. A lower
uptake for cervical cancer screening was found for women
in Great Britain who had changed residence and address in
one study [35], however not in another study [30]. Poor
self-perceived general health status could increase participa-
tion in screening examinations to find the reason for the
poor health status and to invest in better health. This ap-
pears to be the case for general health check-ups such as
blood pressure check and cholesterol test, but not for
female specific cancer screenings such as the mammog-
raphy and the smear test [28]. Psychological factors such as
fear and anxiety of having a cancer diagnosis confirmed in
these female specific health check-ups may prevent women
from attending a female cancer specific health check-up
and these psychological factors are related to a poor health
status [38]. Furthermore, women with poor health status
may be unable to visit the screening location such as the
GP, family clinic or mammography unit, because of physical
limitations. For women with poor health decreased uptake
of mammograms and pap smears has been reported in the
empirical literature. There are mixed results for the effect
of poor health status or comorbidities: in one study screen-
ing rates decreased as comorbidity increased measured by
an index of comorbidity, which was adapted from the
Charlson comorbidity index [39], however in two other
studies mammography utilization was higher among
women with 3 or more stable comorbidities than among
those without comorbidities [40, 41]. Smoking can serve as
an indicator for the weakened preference for health in com-
parison to other goods and smoking individuals show risk
taking behaviour [42]. Women who smoke have poorer
preventative health habits such as a reduced level of phys-
ical activity in comparison to non-smoking women [43].
The predicted influence of smoking was empirically con-
firmed for breast cancer screening with a lower uptake for
smoking women than for non-smoking women [22]. For
some women with non-white ethnic origin, cultural barriers
could exist for both screening examinations, because breast
and cervical cancer screening can be experienced as in-
vading medical procedures into the private sphere of a
woman. In an empirical investigation, ethnicity was the
most important predictor for cervical cancer screening,
with white British women having a higher uptake than
women of other ethnicity [44]. One further study dem-
onstrated a positive association between the uptake of
breast cancer screening and other preventative health
check-ups [45]. A systematic review indicated a positive
influence of taking part in screening examinations and
future health-promoting behaviours and a majority of
the studies showed a positive association between both
screening examinations [46]. However, all of these stud-
ies were cross-sectional or cohort studies and covered a
short time span, and studies did not analyse the tem-
poral sequence of screening examinations over a longer
period with panel data.
Data
The BHPS was used for the analysis of breast and cervical
cancer screening, the BHPS being an annual survey of
households in the UK. It involves a national representative
sample of more than 5,000 households and with individ-
uals age 16 and over [47]. The survey began in 1991 and
all the original individuals were interviewed annually un-
less they dropped out. In our analysis and construction of
the balanced sample, only individuals from England,
Scotland and Wales were selected, because data collection
did not start in Northern Ireland until wave 11. For the
construction of the balanced panel, 17 years of informa-
tion were used: from 1992 to 2008, because in the first
wave only a few individuals were interviewed in 1991,
most in 1992.
Questions about participating in breast and cervical can-
cer screening were in every wave from the start of the
panel survey in 1991 until 2008. For the analysis of breast
and cervical cancer screening behaviour, only women were
included in the sample. For women to be included in our
analysis, provision of both cancer screening examinations
had to be from the NHS; females with private provision or
with NHS and private provision for these health check-up
have been excluded from the analysis. The dependent vari-
able takes the value of 1 in a specific year if the breast can-
cer screening or cervical cancer screening was done and 0
if not. For analysing the policy changes for breast cancer
screening and cervical cancer screening, dummy coding
was chosen: for breast cancer screening and the age group
65–70, all years before and including 2002 were coded
with 0 and all the following years with 1; for cervical can-
cer screening and the age group 25–49, all years before
and including 2003 were coded with 0 and all the following
years with 1.
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Methods
To model the dynamic nature of screening examinations
and because uptake is a binary variable, a dynamic random
effects (RE) panel probit model was used to estimate the
uptake of both screening examinations over the panel
period from 1992 to 2008. In such a model, it is possible to
estimate the effect of state dependence from the same type
of screening examination and spillover effects from the
other type of screening examination and also to control for
unobserved heterogeneity and the correlation between the
individual specific random effects terms. Possible dynamic
spillover effects can exist in a bivariate model from one type
of screening examination (e.g. breast cancer screening) to
the other type of screening examination (e.g. cervical cancer
screening) and vice versa. The influence of household and
individual characteristics on uptake can also be analysed
within such a model.
The formal presentation extends the dynamic random
effects univariate panel probit model to the dynamic
random effects bivariate panel probit model and follows
Alessie et al. [48] and Devicienti et al. [49]. One possibil-
ity for estimating a dynamic random effects panel probit
is the Wooldridge estimator which specifies a relation-
ship between the unobserved time-invariant individual
effect and the observed characteristics and initial condi-
tions. The univariate case for the Wooldridge estimator
can be modelled with the following 3 equations [50].
yit ¼ y0i;t−1γ þ x0itβþ ci þ μit ð1Þ
ci ¼ a0 þ a1yi1 þ X
0
ia2 þ αi ð2Þ
yit ¼ 1; if y

it > 0
0; otherwise
t ¼ 2;…;T

ð3Þ
In the first equation yit indicates the unobserved latent
variable of an individual i at a given time t for taking part
in a specific screening examination, yi,t-1 is the screening
examination decision of the individual i in period t-1, γ is
the coefficient for this variable, x is a vector of time variant
and time invariant covariates, β is the vector of coefficients
associated with these covariates, uit is the random error
term of an individual i in period t with normal distribution
with zero means and unit variances. ci indicates the indi-
vidual specific random effect which is modelled according
to the second equation and Xi are longitudinal averages of
an individual i for specified variables. a0, a1, a2 are parame-
ters which have to be estimated and αi is a term with nor-
mal distribution with zero mean and variance σ2α . A
normal density for the individual specific random effect is
assumed. Correlation between the individual specific ran-
dom effect and time-varying variables of an individual is
allowed by including the average of these variables over
the whole panel observation period in the second equation
[51]. Time-varying variables included in the second equa-
tion can be partitionated into an actual (transitory) and
permanent (averaged) component for the estimation. The
third equation gives the observed binary outcome yit of
taking part in one screening examination for an individual
i in period t. Such a model can estimated with standard
software.
The estimation of such a dynamic random effects panel
probit model can be extended for the bivariate case in the
following way:
y1it ¼ γ11y1i;t−1 þ γ12y2i;t−1 þ x0itβ1 þ c1i þ μ1it ð4Þ
y2it ¼ γ21y2i;t−1 þ γ22y2i;t−1 þ x0itβ2 þ c2i þ μ2it ð5Þ
With
yjit ¼ 1þ yjit > 0
h i
j ¼ 1; 2 t ¼ 2;…;T ð6Þ
yjit is the chance of a woman i in period t to have a can-
cer screening examination j (breast or cervical cancer
examination) expressed as latent variable. β = (β1, β2) is
the vector of coefficients associated with the covariates in
equation (4) and (5). The assumptions for the error terms
μ1it and μ2it are a bivariate normal distribution with a zero
mean and a unit variance for each error term and inde-
pendency over time and a cross-equation covariance of ρ.
Individual specific random effects are c1i and c2i for breast
and cervical cancer screening with a bivariate normal dis-
tribution with variances comorbidity and σ2c2 and covari-
ances σc1, σc1, ρc.
The equation (6) gave the observed binary outcome for
breast cancer screening (y1it) for the individual woman i in
period t, which was equal to 1 if the woman i had a breast
cancer screening examination in period t and 0 otherwise.
Analogue the observed binary outcome for the individual
woman i in period t for cervical cancer screening (y2it)
was equal to 1 if the woman i had a cervical screening
examination in period t and 0 otherwise.
The inclusion of lagged dependent variables for breast
and cervical cancer screening makes a distinction between
unobserved heterogeneity and state dependence possible,
and potential dynamic spillover effects from one type of
cancer screening to the other type of cancer screening for
the women can be analysed. Additionally, such a specifica-
tion allows for correlated unobserved heterogeneity
between the two processes and takes into account the two
initial conditions of the separate processes. It is also pos-
sible to analyse if the correlation in the observed outcomes
for breast and cervical cancer screening is caused by
correlation of unobserved heterogeneity (ρc ≠ 0) or by
spillover effects between both screening examinations (γ12
and γ21 ≠ 0). The dynamic random effects bivariate panel
probit model considered in equations 7 and 8 can be
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simplified in some cases. If the coefficients γ12 and γ21 are
both 0, both equations could be estimated independently
and so both equations could be estimated as a dynamic
random effects univariate panel probit model. If the coeffi-
cients γ12 ≠ 0 or γ21 ≠ 0 and the individual specific random
effects and the error terms of the 2 equations are inde-
pendent, which requires ρ = 0 and, ρc = 0 then equation 7
or equation 8 can be estimated as separate equations. If
this is not the case, then for all other cases both equations
have to be estimated jointly for getting consistent
estimates.
y1it ¼ γ11y1i;t−k þ γ12y2i;t−k þ x0itβ1 þ a10
þ a11y1i1 þ a12y2i1 þ X
0
ia13 þ α1i þ u1it
ð7Þ
y2it ¼ γ21y1i;t−k þ γ22y2i;t−k þ x0itβ2 þ a20
þ a21y1i1 þ a22y2i1 þ X
0
ia23 þ α2i þ u1it
ð8Þ
with
c1i ¼ a10 þ a11y1i1 þ a12y2i1 þ X
0
ia13 þ α1i ð9Þ
c2i ¼ a20 þ a21y1i1 þ a22y2i1 þ X
0
ia23 þ α2i ð10Þ
An alternative instead of using the Wooldridge estima-
tor would be using the Alessie estimator [48] which ex-
tends the Heckman estimator [52] to the bivariate case
for the dynamic random effects panel probit. However,
advantages of using the Wooldridge estimator in com-
parison to the Alessie estimator are: the numbers of param-
eters which have to be estimated are smaller and higher
order dynamics with lagged dependent variables can be
more easily modelled. A dynamic specification with 1-year,
2-year, 3-year lagged dependent variables as explanatory
variables takes into account the existence of policy rules for
the invitation exist for breast and cervical cancer screening
in Great Britain and also that screening examinations from
the previous year could have an inconclusive result with the
consequent need for a further screening examination. This
was especially relevant for the cervical cancer screening
examination before the introduction of LBC. For these rea-
sons, we used the Wooldridge-type estimator and used 3
lags for the modelling of the dynamic structure of both
screening processes. For the initial conditions for breast or
cervical cancer screening for an individual woman i we
used the information about breast or cervical cancer
screening in the three waves from 1992 to 1994.
The Wooldridge estimator assumes a balanced panel,
because selection and attrition can depend on initial con-
ditions. It allows for different initial statuses to have differ-
ent missing data possibilities. Therefore, it is not explicitly
necessary to model selection and attrition as a function
of initial conditions [53]. Important assumptions for
the estimation of the dynamic random effects univariate
and bivariate panel probit model are: the distributional
assumptions on the initial conditions are correct and the
relationship between the unobserved time-invariant indi-
vidual effect and the mean of the observed characteristics
are correctly specified. A further assumption for an un-
biased estimation with regard to initial conditions for
breast and cervical cancer screening is the assumption
that unobserved breast and cervical cancer screening ex-
aminations that happened prior to the panel observation
period are uncorrelated with the observed breast and cer-
vical cancer screening examinations and if these assump-
tions are violated the estimation results could be biased.
The breast cancer screening programme (NHSBSP) and
cervical cancer screening programme (NHSCSP) were
introduced in 1988 before the beginning of the BHPS. For
our estimation technique, it is assumed that female cancer
screening examinations which had been undertaken
before the first wave of the BHPS are uncorrelated with
the cancer screening examinations recorded in the BHPS.
If this assumption is violated, the inclusion of initial con-
ditions of health check-ups for the years 1992 to 1994
could result in biased estimates for our regressions.
The dynamic random effects univariate and bivariate
panel probit models are estimated for breast and cervical
cancer screening with lagged dependent variables as
explaining variables and lags were used up to order 3. This
econometric specification was also chosen in other related
studies [5, 6, 30]. In a first step, a dynamic univariate
pooled probit with the assumption of exogenous lags was
applied and the dynamic random effects univariate panel
probit for the breast and cervical cancer screening were
estimated. In a second step, a dynamic bivariate pooled
probit model and a dynamic random effects bivariate
panel probit were estimated2. These estimations of the
bivariate probit models were compared with the estima-
tions for the univariate probit models and also both bivari-
ate probit models were compared with each other. As a
robustness check for the dynamic random effects bivariate
panel probit, a further specification was tested for the pos-
sible endogeneity of a GP visit for breast and cervical can-
cer screening. Additionally, unbalanced panels were
estimated and their results were compared with balanced
panels.
Results
The balanced panel for breast and cervical cancer screen-
ing consisted of 844 women with 11816 observations from
1992 to 2008. Breast and cervical cancer screening infor-
mation was available over the entire panel period. In our
analysis, we categorized age groups for breast cancer
screening as follows: 16 to 49 (reference category), 50 to
64, 65 to 70, age 71 and over. For cervical cancer screen-
ing, we also categorized by age groups: 16 to 19 (reference
category), 20 to 24, 25 to 49, 50 to 64, age 65 and over.
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Household income was deflated and transformed in per
capita income using the modified OECD scale to adjust
for household size and needs [54]. Actual income was
defined as the total equivalised and deflated household
annual income divided by 100 in the actual wave and
averaged (permanent) household income was defined as
annual household income over the 17 years between 1992
and 2008. The International Standard Classification of
Education (ISCED) was used for the categorisation of edu-
cational levels with tertiary, secondary and primary educa-
tion (reference category) as different levels. Health status
was self-rated and included in our analysis with categories
from excellent (1) as reference category, good (2), fair (3),
poor (4) to very poor (5) [55].
Table 1 shows the proportion of women who visited
breast or cervical screening in the period between 1992
and 1998 for every year. Table 2 displays the number
(sum) of years in which a woman had attended for breast
or cervical cancer screening during the 17 year period
from 1992 to 2008. The uptake rate was 14.0 % for breast
cancer screening and 22.0 % for cervical cancer screening
over the whole analysed period. The average number of
visits for breast or cervical cancer screening examinations
over the whole period (1992 to 2008) was 2.38 and 3.78.
The conditional probabilities of having a breast or cer-
vical cancer screening in the recent year, dependent on
having a breast or cervical cancer screening in the
previous year are shown in Table 3. The conditional prob-
abilities were especially higher for the same type of screen-
ing examination one and three years before.
Table 4 presents descriptive statistics of the variables
used in our estimates for the breast and cervical cancer
screening examinations. The explanatory variables
Table 1 Uptake rate for breast and cervical cancer screening
during the 17 years period from 1992 to 2008
Health check-up Breast cancer screening Cervical cancer screening
1992 15.05% 29.62%
1993 14.69% 29.86%
1994 12.44% 26.78%
1995 14.10% 26.07%
1996 10.78% 25.95%
1997 13.74% 24.41%
1998 13.74% 24.76%
1999 12.56% 18.60%
2000 12.68% 21.68%
2001 14.22% 22.87%
2002 13.03% 18.48%
2003 15.28% 20.85%
2004 13.86% 17.54%
2005 14.34% 17.06%
2006 16.00% 16.82%
2007 15.88% 16.71%
2008 15.88% 15.17%
Total 14.02% 21.95%
Source: BHPS. Balanced panels consisted for breast cancer screening of 844
women from 11,816 observations
Table 2 Number of years with a breast or cervical screening
visit during the 17 years period from 1992 to 2008
Health check-up Breast cancer screening Cervical cancer screening
0 39.6% 22.9%
1 11.7% 8.8%
2 9.7% 9.4%
3 8.5% 11.6%
4 10.7% 10.1%
5 3.8% 8.8%
6 6.3% 9.2%
7 3.3% 5.6%
8 2.8% 4.7%
9 1.8% 3.4%
10 0.8% 1.9%
11 0.2% 1.5%
12 0.2% 1.1%
13 0.1% 0.6%
14 0.4% 0.1%
15 0.0% 0.2%
16 0.0% 0.1%
17 0.0% 0.0%
Total 100.00% 100.00%
Source: BHPS. Balanced panels consisted for breast cancer screening of 844
women from 11,816 observations
Table 3 Conditional probabilities of a visit of a cancer screening
visit in current year dependent from a visit in the previous year
Health check-up Probability
Breast cancer screening (t) | Breast cancer screening (t-1) 0.334
Breast cancer screening (t) | Breast cancer screening (t-2) 0.302
Breast cancer screening (t) | Breast cancer screening (t-3) 0.462
Breast cancer screening (t) | Cervical cancer screening (t-1) 0.240
Breast cancer screening (t) | Cervical cancer screening (t-2) 0.233
Breast cancer screening (t) | Cervical cancer screening (t-3) 0.276
Cervical cancer screening (t) | Breast cancer screening (t-1) 0.140
Cervical cancer screening (t) | Breast cancer screening (t-2) 0.134
Cervical cancer screening (t) | Breast cancer screening (t-3) 0.151
Cervical cancer screening (t) | Cervical cancer screening (t-1) 0.393
Cervical cancer screening (t) | Cervical cancer screening (t-2) 0.320
Cervical cancer screening (t) | Cervical cancer screening (t-3) 0.488
Source: BHPS. Balanced panels consisted for breast cancer screening of 844
women from 11,816 observations
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consist of individual and household characteristics. All
time varying variables were averaged over the whole panel
period and used in the auxiliary regressions for the
Wooldridge-type estimators for determining their effect on
the individual specific term.
The results for the dynamic univariate pooled probit
model without random effects, initial conditions and the
dynamic random effects panel probit model with initial
conditions (Wooldridge estimator) for breast and cervical
cancer screening are given in tables 5 and 63. The estima-
tion of these and the following models use the same bal-
anced sample of 844 individuals and 11816 observations.
For both cancer screening examinations, taking part in
screening examinations of the same type one year and
three years before showed a strong positive influence on
the current screening examination. These results were
identical in both econometric specifications for breast and
cervical cancer screening. For the univariate Wooldridge-
type estimator, the coefficient was 0.108 for the first order
own-effect lagged dependent variable and 0.790 for the
third order own-effect lagged dependent variable. Similar
results with a positive significant influence were found for
the first order own-effect lagged dependent variable in the
cervical cancer screening equation with a coefficient of
0.232 and a coefficient of 0.559 for the third order own-
effect lagged dependent variable. Additionally, there were
cross-lagged dependent variable (spillover) effects for the
third order lag. The cross-lagged dependent variable effect
for the third order lagged cervical cancer screening variable
in the breast cancer screening regression was significant
with a coefficient of 0.103. In a similar way the cross-
lagged dependent variable effect for the third order lagged
breast cancer screening examinations in the cervical cancer
screening regression was significant with a coefficient of
0.187. It can be seen from Tables 5 and 6 that the coeffi-
cients for the dynamic univariate pooled probit and the
dynamic random effects univariate panel probit model with
initial conditions for breast and cervical in cancer screen-
ing were similar and the coefficients for the own-lagged
dependent variables in the dynamic univariate pooled probit
model were higher, overstating state dependence. A com-
parison of the results for the unbalanced and balanced
panels for the dynamic pooled univariate probit and the uni-
variate Wooldridge-type estimator showed similar results4.
To obtain valid estimates for the univariate estimation
of breast and cervical cancer screening in comparison to
the bivariate estimation, the implicit assumptions were
made that the correlation of the individual specific ran-
dom effects terms across the 2 equations was equal to 0
and the coefficients of the cross-lagged variables for the
screening examinations were equal to 0. Shown in
Table 7 are the estimations for the uptake of breast and
cervical cancer screening in Great Britain with a dy-
namic bivariate pooled probit model and the dynamic
random effects bivariate panel probit with initial condi-
tions (bivariate Wooldridge-type) estimator. The own-
and cross-lagged dependent variable effects were also
visible in the dynamic bivariate pooled probit model and
in the dynamic random effects bivariate panel probit
model estimations. In the breast cancer screening equa-
tion, the coefficient for the first order own-effect lagged
dependent variable was 0.116; the coefficient for the
third order own-effect lagged dependent variable was 0.797
for the bivariate Wooldridge-type estimators (specification
with a GP visit during the last 12 months). Similar results
exist in the cervical cancer screening equation for the first
order own-effect lagged dependent variable with a coeffi-
cient of 0.227 and a coefficient of 0.555 for the third order
own-effect lagged dependent variable. For the third order
cross-lagged dependent variable, the cervical coefficient
was 0.083 in the breast cancer screening equation and the
breast coefficient in the cervical cancer screening equation
was 0.181. The dynamic bivariate pooled probit model and
the dynamic random effects bivariate panel probit showed
similar coefficients for the socioeconomic variables and the
coefficients for the lagged dependent variables were higher
in the first model, because of the exogeneity assumption.
We investigated whether the two equations could be es-
timated separately, because the nonzero coefficients of the
cross-lagged dependent variables imply that the equations
Table 4 Descriptive characteristics for the balanced panels of
breast and cervical cancer screening in Great Britain. Sample
characteristics for the balanced sample of women from
1992 to 2008
Health check-up Frequency or mean/SD
Total equivalised and deflated HH
annual income (mean/SD)
3.10/(1.84)
Living with partner 0.72
Number of children in household (mean/SD) 0.52/(0.92)
Secondary education (ISCED) 0.42
Tertiary education (ISCED) 0.32
Employed part-time or full-time 0.52
GP visit during last 12 months 0.80
Health status good 0.47
Health status fair 0.23
Health status poor 0.07
Health status very poor 0.02
Status smoking 0.17
Moved residence within Great Britain 0.05
Region Scotland 0.08
Region Wales 0.05
Ethnic non-white 0.01
Age (mean/SD) 51.05/(15.57)
Source: BHPS. Balanced panels consisted for breast cancer screening of 844
women from 11,816 observations
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Table 5 Estimates of the univariate pooled and dynamic RE panel probit breast cancer model
Univariate pooled probit Univariate RE panel probit
Coeff. Robust SE Coeff. SE
Breast cancer screening one year before (t-1) 0.352*** (0.053) 0.108** (0.049)
Breast cancer screening two years before (t-2) 0.205*** (0.046) -0.018 (0.048)
Breast cancer screening three years before (t-3) 0.985*** (0.047) 0.790*** (0.044)
Cervical cancer screening one year before (t-1) 0.016 (0.041) 0.023 (0.046)
Cervical cancer screening two years before (t-2) -0.056 (0.041) -0.067 (0.046)
Cervical cancer screening three years before (t-3) 0.103*** (0.038) 0.103** (0.044)
Breast cancer screening in 1992 0.092 (0.065)
Breast cancer screening in 1993 0.037 (0.065)
Breast cancer screening in 1994 0.173*** (0.067)
Cervical cancer screening in 1992 0.018 (0.051)
Cervical cancer screening in 1993 0.069 (0.052)
Cervical cancer screening in 1994 0.021 (0.055)
Averaged Total equivalised HH income/100 -0.015 (0.026)
Averaged Living with partner 0.111 (0.135)
Averaged Number of children in household 0.027 (0.065)
Averaged Secondary education (ISCED) -0.586 (0.423)
Averaged Tertiary education (ISCED) -0.483 (0.518)
Averaged employment status part-time or full-time 0.378*** (0.105)
Averaged GP visit during last 12 months 0.409*** (0.142)
Averaged Health status good -0.018 (0.128)
Averaged Health status fair -0.002 (0.151)
Averaged Health status poor 0.189 (0.248)
Averaged Health status very poor -0.334 (0.441)
Averaged status smoker 0.100 (0.141)
Averaged Moved residence within GreatBritain -0.413 (0.383)
Averaged age 0.030*** (0.004)
Total equivalised and deflated HH annual income -0.009 (0.011) 0.004 (0.015)
Living with partner 0.087** (0.044) 0.031 (0.116)
Number of children in household -0.219*** (0.036) -0.141*** (0.049)
Secondary education (ISCED) -0.015 (0.043) 0.624 (0.419)
Tertiary education (ISCED) 0.011 (0.048) 0.561 (0.511)
Employed part-time or full-time -0.128*** (0.041) -0.212*** (0.065)
GP visit during last 12 months 0.250*** (0.048) 0.191*** (0.058)
Health status good 0.087* (0.050) 0.066 (0.063)
Health status fair 0.058 (0.058) 0.011 (0.076)
Health status poor 0.060 (0.077) 0.002 (0.101)
Health status very poor 0.002 (0.133) 0.031 (0.152)
Status smoking -0.133*** (0.051) -0.207* (0.124)
Moved residence within Great Britain -0.029 (0.083) 0.046 (0.093)
Region Scotland 0.001 (0.070) -0.001 (0.088)
Region Wales 0.074 (0.074) 0.156 (0.097)
Ethnic non-white -0.001 (0.118) 0.074 (0.216)
Age between 50 and 64 0.628*** (0.043) 0.634*** (0.046)
Labeit and Peinemann Health Economics Review  (2015) 5:32 Page 9 of 17
can only be separated if the correlation of the individual
specific random effects and the correlation of the error
terms are zero. The results of the bivariate Wooldridge-
type estimator show that first the hypothesis of independ-
ence between the error terms with a correlation had to be
rejected, because ρ with a value of 0.170 was significantly
different from 0. Also the individual specific random
effects terms were correlated, because ρa with a value of
0.219 was statistically significant different from 0.
Higher uptake for breast and cervical cancer screening
examinations was observed for women who visited their
GP within the previous year. Women aged 50 to 64 had
an increased uptake for breast cancer screening examina-
tions in comparison with women age 16 to 49 (reference
category); women age 25 to 49 had an increased uptake
for cervical cancer screening examinations in comparison
with the reference category of women age 16 to 19.
Women age 65 to 70 had an increased uptake of breast
cancer screening after the change of policy rules in 2002.
However, for women age 25 to 49, the uptake did not
increase for cervical cancer screening after the change of
policy rules for recall in 2003. For the breast cancer
screening equation, the variables that had a negative im-
pact were having a higher number of children and being
employed, but these variables did not have a negative im-
pact on the cervical cancer screening equation. Both cancer
screening equations were not influenced by the levels of
self-assessed health status, smoking status, household
income or living with a partner. A further specification for
testing the possible endogeneity of a GP visit in the dy-
namic random effects bivariate panel probit model by not
including this variable gave very similar results in compari-
son to the specification with a GP visit.
Discussion
Our analysis of the BHPS investigated for the first time
the determinants of screening uptake for breast and cer-
vical cancer screening and possible spillover effects with a
dynamic bivariate panel probit model. A dynamic random
effects bivariate panel probit model was used for the esti-
mation over a period for 17 years from 1992 to 2008 for
Great Britain with a balanced panel. The uptake of breast
and cervical cancer screening was modelled with lagged
dependent variables up to order 3 and it was controlled for
individual heterogeneity. The strong influence of past
screening behaviour with a highly significant effect of the
own first order lag and third order lag for breast and cer-
vical cancer screening shows that past screening behaviour
influences actual behaviour. These results can be inter-
preted as persistence in screening behaviour and state de-
pendence [56]. The reasons for the strong positive state
dependence with respect to the effects of own lagged
dependent variables for breast and cervical cancer screen-
ing are the adherence to screening policy rules for the invi-
tation in Great Britain. The NHS Breast and Cervical
Screening Programmes give explicit rules for the time
interval between screening examinations [7, 11]. The im-
portance of these screening rules on current behaviour can
especially be seen in the high predictive value of the same
type of screening examination three years before. The coef-
ficients for the same type of screening examinations one
year before were significantly positive for both types of
cancer screening examinations. Necessary control screen-
ing examinations checked unclear test results from the
previous health check-up one year year before and could
especially explain the coefficient for the first order lag.
However, with existing data from the BHPS, it is not pos-
sible to differentiate between these different possibilities.
Initial conditions show relevance for both types of screen-
ing examinations. If initial conditions for the first three
years had not been taken into account, the influence of
past screening behaviour on actual behaviour would have
been overestimated.
Our empirical investigation showed additionally the im-
portance of cross-lagged dependent variable effects for the
third order lags for both types of screening examinations.
Visiting one type of screening examination enhanced for
the third order lagged variable of one type of screening
examination the uptake of the other screening examin-
ation. This result could be explained by a spillover effect
that an individual woman is more accessible for preventive
information after visiting one type of screening examin-
ation in the past. Another possibility could be that unob-
served variables are correlated with the lagged dependent
variables. Heterogeneity with unobserved characteristics
plays a role for breast and cervical cancer screening. It is
responsible for about one third of the unsystematic vari-
ation in each of the equations. The correlation of the two
Table 5 Estimates of the univariate pooled and dynamic RE panel probit breast cancer model (Continued)
Age between 65 and 70 -0.246*** (0.092) -0.687*** (0.094)
Age 71 and older -0.532*** (0.080) -1.154*** (0.099)
Breast screening policy change 0.407*** (0.098) 0.556* (0.105)
Constant -1.681*** (0.086) -3.746*** (0.277)
σα 0.363*** (0.036)
Source: BHPS. Balanced panels consisted for breast cancer screening of 844 women from 11,816 observations. Robust SEs are displayed in parentheses, to account
for individual repeated observations in the panel. *p<0.1; **p<0.05; ***p<0.01
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Table 6 Estimates of the univariate pooled and dynamic RE panel probit cervical cancer model
Univariate pooled probit Univariate RE panel probit
Coeff. Robust SE Coeff. SE
Breast cancer screening one year before (t-1) 0.046 (0.048) 0.010 (0.050)
Breast cancer screening two years before (t-2) 0.032 (0.048) 0.006 (0.051)
Breast cancer screening three years before (t-3) 0.205*** (0.047) 0.187*** (0.050)
Cervical cancer screening one year before (t-1) 0.423*** (0.038) 0.232*** (0.039)
Cervical cancer screening two years before (t-2) -0.109*** (0.036) -0.289*** (0.039)
Cervical cancer screening three years before (t-3) 0.729*** (0.039) 0.559*** (0.036)
Breast cancer screening in 1992 0.204*** (0.044)
Breast cancer screening in 1993 0.203*** (0.044)
Breast cancer screening in 1994 0.132*** (0.046)
Cervical cancer screening in 1992 -0.010 (0.072)
Cervical cancer screening in 1993 -0.055 (0.071)
Cervical cancer screening in 1994 0.239*** (0.069)
Averaged total equivalised HH income/100 0.015 (0.022)
Averaged living with partner 0.058 (0.107)
Averaged number of children in household 0.020 (0.046)
Averaged secondary education (ISCED) -0.198 (0.383)
Averaged tertiary education (ISCED) -0.296 (0.426)
Averaged employment status part-time or full-time -0.051 (0.093)
Averaged GP visit during last 12 months -0.068 (0.121)
Averaged health status good -0.007 (0.107)
Averaged health status fair -0.109 (0.136)
Averaged health status poor 0.189 (0.233)
Averaged health status very poor 0.148 (0.375)
Averaged status smoker -0.135 (0.118)
Averaged moved residence within Great Britain 0.117 (0.286)
Averaged age -0.007* (0.004)
Total equivalised and deflated HH annual income 0.012 (0.009) 0.004 (0.013)
Living with partner 0.124*** (0.046) 0.099 (0.086)
Number of children in household 0.019 (0.017) -0.001 (0.031)
Secondary education (ISCED) 0.015 (0.050) 0.196 (0.378)
Tertiary education (ISCED) 0.063 (0.053) 0.324 (0.418)
Employed part-time or full-time 0.039 (0.038) 0.060 (0.056)
GP visit during last 12 months 0.378*** (0.046) 0.422*** (0.048)
Health status good -0.046 (0.039) -0.042 (0.051)
Health status fair -0.052 (0.046) -0.037 (0.063)
Health status poor -0.035 (0.064) -0.067 (0.089)
Health status very poor -0.140 (0.106) -0.258* (0.145)
Status smoking -0.025 (0.063) -0.056 (0.070)
Moved residence within Great Britain 0.037 (0.045) 0.137 (0.100)
Region Scotland 0.048 (0.051) 0.051 (0.074)
Region Wales -0.109 (0.081) -0.111 (0.092)
Ethnic non-white -0.200* (0.109) -0.272 (0.187)
Age between 20 and 24 0.596*** (0.143) 0.543*** (0.175)
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individual specific random terms is positive and significant
at a 10-% level. This means that the persistent unobserved
characteristics of a woman, which are also responsible for
a higher or lower uptake of breast cancer screening exam-
ination can explain the higher or lower uptake of a cervical
cancer screening examination and vice versa. The signifi-
cant positive correlation of the error terms means has as a
consequence that idiosyncratic events or shocks in a time
period that influences the decision of a woman to visit one
type of cancer screening examination also influences the
decision of a woman to visit the other type of cancer
screening examination. The significance of the cross-
lagged variables and the significant correlation of individual
specific random terms and error terms show that both
types of screening examinations are simultaneously deter-
mined and interrelated and that both equations cannot be
estimated separately and have to be estimated jointly [49].
Therefore, screening examinations cannot be analysed in-
dependent from each other and a change in the screening
policy rules of one examination would influence its own
uptake, but it would also influence the uptake of the other
screening examination, because of possible spillover effects
and a decision maker should be aware of these effects.
Considering the effect of the other covariates for breast
and cervical cancer screening the uptake is not explained
by all the same variables in both screening examinations.
The variables age and a previous GP visit have the same
influence for both screening examinations. The relevance
of the policy rules for the invitation with specified age
intervals for cervical and breast cancer screening within
both programmes can be seen in our specifications with
the highest probability of uptake in the recommended age
groups and this effect can also be seen in other analyses
[6, 30]. The finding of a lower screening uptake in the old-
est age group in comparison to younger age groups is in
accordance with the shorter pay-off period for older
women from the human capital theory approach. Further-
more, a GP visit in the last year leads to a higher uptake of
breast and cervical cancer screening. The GP plays an im-
portant role as gatekeeper and in prevention by referring a
patient for specific screening examinations (e.g. breast and
cervical cancer screening) or by doing the screening
examination as is in the case for cervical cancer screening
[37]. Our results are similar to those of an Italian study
which analysed the uptake of breast and cervical cancer
screening with a recursive probit. Estimations from the
Italian study showed that GP visits led to an increased up-
take of breast and cervical screening [29].
Health status can be interpreted as a proxy for health
and women with a poor self-assessed health status could
have a high demand for these two cancer screening
examinations in order to invest in prevention activities
and to increase their health stock. However, poor self-
assessed health status can influence uptake also in other
ways such as changed perceptions on the preventability of
health problems and diseases. Individuals with a poorer
health status also expressed less interest in receiving pre-
vention information [57]. Psychological factors, such as
fear and anxiety about confirmation of a disease, can be re-
lated to a poor health status and this correlation could be
especially relevant for the both analysed female cancer
screening examinations. Also, women with a poor health
status may be unable to visit the screening location. These
possibilities of influence could cancel one another out. In-
dividual and household characteristics such as employ-
ment, number of children in the household and smoking
had a non-uniform influence on both uptakes. In a system-
atic review which analysed the determinants of screening
uptake for different cancer screenings, none of the analysed
socioeconomic variables had the same influence in all can-
cer screening examinations [27]. There are similar results
for some socioeconomic variables and health-related vari-
ables, however there are also some differences when our
results on the uptake of breast and cervical cancer screen-
ing are compared with other studies which had analysed
the uptake behaviour for Great Britain and used the BHPS.
Analysis of breast cancer screening uptake with the BHPS
was done in one study with a balanced sample [6]. Identical
results were found for the relevance of previous screening
history, a GP visit, age and self-assessed health status.
However, results were different to own results for educa-
tion level, marital status and the averaged income term
(Mundlak term), because they were significant in this ana-
lysis. Analysis of cervical cancer screening uptake with the
BHPS was done in a further analysis with a balanced sam-
ple [5]. In this analysis, previous screening history, age and
Table 6 Estimates of the univariate pooled and dynamic RE panel probit cervical cancer model (Continued)
Age between 25 and 49 0.453*** (0.065) 0.414*** (0.092)
Age between 50 and 64 0.191*** (0.055) 0.208*** (0.068)
Age 65 and older -0.747*** (0.069) -0.763*** (0.085)
Cervical screening policy change -0.072* (0.041) -0.114* (0.045)
Constant -1.818*** (0.087) -1.532*** (0.266)
σα 0.349*** (0.031)
Source: BHPS. Balanced panels consisted for cervical cancer screening of 844 women from 11,816 observations. Robust SEs are displayed in parentheses, to
account for individual repeated observations in the panel. *p<0.1; **p<0.05; ***p<0.01
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Table 7 Estimates of the bivariate pooled and dynamic RE panel probit breast and cervical cancer model
Bivariate pooled probit Bivariate pooled probit Bivariate RE panel probit Bivariate RE panel probit Bivariate RE panel probit without GP
Breast Cervical Breast Cervical Breast Cervical
Coeff. Robust SE Coeff. SE Coeff. SE Coeff. SE Coeff. SE Coeff. SE
Breast cancer screening 1 year before 0.351*** (0.053) 0.052 (0.048) 0.116** (0.048) -0.005 (0.052) 0.116** (0.048) 0.001 (0.052)
Breast cancer screening 2 years before 0.207*** (0.046) 0.043 (0.048) -0.009 (0.048) -0.002 (0.052) -0.009 (0.048) 0.005 (0.052)
Breast cancer screening 3 years before 0.986*** (0.047) 0.216*** (0.047) 0.797*** (0.044) 0.181*** (0.052) 0.795*** (0.044) 0.187*** (0.052)
Cervical cancer screening 1 year before 0.009 (0.041) 0.419*** (0.038) -0.005 (0.049) 0.227*** (0.039) 0.005 (0.049) 0.237*** (0.039)
Cervical cancer screening 2 years before -0.060 (0.041) -0.110*** (0.036) -0.087* (0.048) -0.291*** (0.039) 0.083* (0.048) -0.279*** (0.039)
Cervical cancer screening 3 years before 0.100*** (0.038) 0.726*** (0.039) 0.083* (0.046) 0.555*** (0.036) 0.089* (0.046) 0.559*** (0.036)
Breast cancer screening in 1992 0.096 (0.064) 0.001 (0.072) 0.103 (0.065) -0.005 (0.071)
Breast cancer screening in 1993 0.034 (0.064) -0.045 (0.072) 0.061 (0.065) -0.035 (0.071)
Breast cancer screening in 1994 0.173*** (0.066) 0.258*** (0.070) 0.204*** (0.067) 0.265*** (0.069)
Cervical cancer screening in 1992 0.011 (0.051) 0.204*** (0.044) 0.017 (0.051) 0.202*** (0.044)
Cervical cancer screening in 1993 0.068 (0.051) 0.206*** (0.045) 0.076 (0.052) 0.204*** (0.044)
Cervical cancer screening in 1994 0.034 (0.055) 0.134*** (0.046) 0.057 (0.055) 0.142*** (0.046)
Longitudinal averaged Xit Yes Yes Yes Yes
Total equivalised HH annual income -0.009 (0.011) 0.012 (0.009) 0.004 (0.015) 0.004 (0.013) 0.004 (0.015) 0.002 (0.013)
Living with partner 0.088** (0.044) 0.122*** (0.046) 0.036 (0.115) 0.098 (0.086) 0.034 (0.115) 0.095 (0.085)
Number of children in household -0.218*** (0.036) 0.012 (0.017) -0.139*** (0.049) -0.003 (0.031) -0.142*** (0.049) -0.012 (0.031)
Secondary education (ISCED) -0.014 (0.043) 0.012 (0.050) 0.676 (0.423) 0.213 (0.380) 0.662 (0.424) 0.188 (0.378)
Tertiary education (ISCED) 0.012 (0.048) 0.059 (0.053) 0.618 (0.514) 0.349 (0.421) 0.574 (0.514) 0.310 (0.418)
Employed part-time or full-time -0.126*** (0.041) 0.026 (0.038) -0.205*** (0.065) 0.052 (0.056) -0.210*** (0.065) 0.043 (0.056)
GP visit during last 12 months 0.254*** (0.048) 0.377*** (0.046) 0.195*** (0.058) 0.422*** (0.048) - - - -
Health status good 0.085* (0.050) -0.045 (0.039) 0.068 (0.063) -0.041 (0.051) 0.093 0.062 0.018 (0.049)
Health status fair 0.056 (0.058) -0.052 (0.046) 0.012 (0.076) -0.037 (0.063) 0.047 (0.075) 0.049 (0.061)
Health status poor 0.055 (0.078) -0.037 (0.064) 0.002 (0.101) -0.068 (0.089) 0.042 (0.100) 0.033 (0.088)
Health status very poor 0.007 (0.133) -0.146 (0.107) 0.045 (0.151) -0.261* (0.145) 0.089 (0.151) -0.161 (0.144)
Status smoking -0.129** (0.051) -0.031 (0.063) -0.207* (0.123) 0.131 (0.100) -0.221* (0.123) 0.095 (0.100)
Moved residence within Great Britain -0.028 (0.082) 0.033 (0.045) 0.051 (0.093) -0.060 (0.070) 0.052 (0.093) -0.065 (0.069)
Region Scotland 0.005 (0.069) 0.049 (0.051) 0.013 (0.086) 0.059 (0.074) 0.032 (0.087) 0.080 (0.073)
Region Wales 0.071 (0.074) -0.112 (0.081) 0.144 (0.096) -0.112 (0.091) 0.155 (0.097) -0.104 (0.090)
Ethnic non-white 0.001 (0.120) -0.201* (0.107) 0.073 (0.211) -0.269 (0.188) 0.072 (0.217) -0.255 (0.186)
Age between 50 and 64 0.625*** (0.043) 0.630*** (0.046) 0.628*** (0.046)
Age between 65 and 70 -0.269*** (0.092) -0.706*** (0.094) -0.690*** (0.095)
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Table 7 Estimates of the bivariate pooled and dynamic RE panel probit breast and cervical cancer model (Continued)
Age 71 and older -0.529*** (0.080) -1.144*** (0.098) -1.114*** (0.099)
Age between 20 and 24 0.678*** (0.143) 0.621*** (0.176) 0.644*** (0.175)
Age between 25 and 49 0.528*** (0.066) 0.480*** (0.093) 0.481*** (0.093)
Age between 50 and 64 0.238*** (0.055) 0.248*** (0.068) 0.242*** (0.046)
Age 65 and older -0.707*** (0.069) -0.751*** (0.085) -0.722*** (0.084)
Breast screening policy change 0.426*** (0.099) 0.574*** (0.104) -0.722*** (0.084)
Cervical screening policy change -0.076* (0.041) -0.118*** (0.045) -0.140*** (0.044)
Constant -1.680*** (0.086) -1.856*** (0.087) -3.676*** (0.270) -1.633 (0.268) -1.432*** (0.258)
σα1 0.355*** (0.036) 0.370*** (0.035)
σα2 0.359*** (0.032) 0.352*** (0.031)
ρ 0.173*** (0.028) 0.170*** (0.026) 0.179*** (0.298)
ρα 0.219* (0.121) 0.214* (0.117)
Source: BHPS. Balanced panels consisted for breast and cervical cancer screening of 844 women from 11,816 observations. Robust SEs are displayed in parentheses, to account for individual repeated observations in
the panel. *p<0.1; **p<0.05; ***p<0.01
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a GP visit were significant for cervical cancer screening in
Great Britain. Our results were confirmed by another study
which analysed the uptake of cervical cancer screening up-
take in England with an unbalanced panel for the first 12
waves of the BHPS until 2003 [30]. Only one analysis com-
pared the sociodemographic determinants for the uptake
of breast and cervical cancer screening at the same time
for Great Britain with a cross-sectional survey [44]. Results
for the effects of determinants on the uptake of both
female cancer screening examinations were different,
because level of education, occupational classification and
ethnicity were not significant; only indicators for wealth
were positively significant. For having a smear test, a higher
educational level, and white British ethnicity were posi-
tively significant. But indicators for wealth or occupational
classification were not significant. This is one of the few
studies that compared the determinants of the uptake of
breast and cervical screening to find different determinants
to be responsible for the uptake of both screening exami-
nations. An advantage of this analysis lies in the fact that
the same estimation sample was used for both screening
examinations. However, unobserved heterogeneity and
state dependency could not be taken into account with
cross-sectional data in this analysis and this could explain
the different results to the results of our own study.
Several limitations exist in our analysis. First, there
was no information about results from previous mam-
mographies and smear tests available and so it cannot be
decided if the screening test is a reexamination screening
examination according to the policy rules or a control
examination because of inconclusive test results one year
before. Second, visiting breast and cervical cancer screen-
ing examinations is self-reported and could be influenced
by a recall bias [58]. Third, no personal or family history
of breast or cervical cancer was available in the BHPS and
women with a family history of cancer belong to a high
risk population. For these women, more frequent mam-
mography was not recommended until recently. It is now
recommended by the National Institute for Health and
Care Excellence (NICE) that women with a family history
of breast cancer should start having screening mammo-
grams every year in their 40’s [59]. It has been shown that
these women can have a higher uptake of both screening
examinations [60, 61]. Fourth, there was no information
about the level of trust in the GP or in the NHS available.
It has been shown that doing a breast cancer or cervical
cancer screening can be dependent on the trust in these
institutions [29]. Fifth, no information about the charac-
teristics of the screening unit was available. Characteristics
of the screening unit such as structure and organization of
medical services performing the screening test can influ-
ence the uptake rate. This association has been shown for
cervical cancer screening uptake and general practice
factors in England [62]. A sixth limitation comes from not
using detailed microgeographic information, because up-
take rates for health check-ups can be higher in affluent
and less deprived areas [63]. Seventh, there was no infor-
mation about women’s attitude to being screened and
belief about the attitudes of near relatives although it has
been shown that these attitudes can also be of significance
for the uptake rate [64].
Conclusions
The innovative feature of our article is the simultaneous
analysis of uptake of breast and cervical cancer screening
using a dynamic random effects bivariate panel probit
model with initial conditions (Wooldridge-type estimator
for a bivariate panel probit) for a balanced sample. No re-
search exists until now on how different types of screening
examinations can influence each other. Our investigation
shows the high relevance of past screening behaviour and
state dependency for the same type of cancer screening.
Past uptake of the same type of screening examination
increases the chances of recent uptake for a breast or cer-
vical cancer screening examination even after controlling
for covariates and unobserved heterogeneity. Additionally,
there were dynamic spillover effects from one type of can-
cer screening examination to the other type of cancer
screening examination for the third order lag. Error terms
of both equations and individual specific terms are con-
temporaneously correlated which as a consequence means
that the uptake of both screening examinations has to be
estimated simultaneously. A policy implication of our re-
sults is that promoting uptake of one type of prevention
activity can enhance the uptake of the other type of pre-
vention activity.
Endnotes
1As later explained in the methods section Northern
Ireland was excluded from our analysis with the used
dataset (BHPS) and so the term Great Britain is used in-
stead of United Kingdom (UK).
2The Wooldridge estimator for the bivariate case is es-
timated as a simulated Maximum Likelihood estimator
with 2RN Halton draws. N is the number of individuals
and R is the number of replications and we used for the
number of replications 60.
3The coefficients of the dynamic random effects panel
probit and the pooled panel probit model have different
normalizations. For comparing the coefficients of both
estimations it is necessary to rescale the coefficients of
one equation, i.e. the coefficients of the dynamic random
effects model have to be multiplied by 1−σ2α
 −1=2
if they
are compared with dynamic pooled probit model.
4Results for the unbalanced panel estimations are
available from the authors on request.
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